This was not linked to an intrinsic inability of intestinal ILCs to provide T-cell help, as in vitro IL-1β- and IL-18-stimulated ILCs from non-affected as well as cancer tissue readily upregulated HLA-DR and co-stimulatory molecules. This evidence concerns the gene IL1B and cancer.